Title:
抗ＣＤ７９Ｂ抗体を含む免疫複合体
Document Type and Number:
Japanese Patent JP2015523380
Kind Code:
A
Abstract:
本発明は、ピロロベンゾジアゼピンに共有結合された抗ＣＤ７９ｂ抗体および免疫複合体ならびにそれらを使用する方法を提供する。【選択図】 図１Ａ、図１Ｂ
More Like This:
| WO/2005/097832 | HUMANIZED ANTI-TGF-BETA ANTIBODIES |
| WO/2022/006534 | TARGETING SERPIN B9 IN CANCER |
| JP2024012431 | Anti-BCMA antibodies and their uses |
Inventors:
Polakis, Paul
Andrew Polson
Spencer, Susan Diane
Yui, Shan-fan
Andrew Polson
Spencer, Susan Diane
Yui, Shan-fan
Application Number:
JP2015521675A
Publication Date:
August 13, 2015
Filing Date:
July 08, 2013
Export Citation:
Assignee:
Genentech, Incorporated
International Classes:
A61K39/395; A61K31/5517; A61K45/00; A61P35/00; A61P35/02
Domestic Patent References:
| JP2011514146A | 2011-05-06 |
Foreign References:
| WO2011130598A1 | 2011-10-20 |
Other References:
POLSON,A.G. ET AL.: ""Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma"", BLOOD, vol. 110, no. 2, JPN6017012018, July 2007 (2007-07-01), pages 616 - 623, ISSN: 0003533586
Attorney, Agent or Firm:
Sonoda Yoshitaka
Kobayashi Yoshinori
Kobayashi Yoshinori